Journal
/
Developmental Biology
/
Uso del trapianto di cellule staminali ematopoietiche per valutare l'origine della sindrome Myelodysplastic
JoVE Journal
Developmental Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Developmental Biology
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Please note that all translations are automatically generated. Click here for the English version.

Uso del trapianto di cellule staminali ematopoietiche per valutare l'origine della sindrome Myelodysplastic

italiano

Automatically Generated

9,679 Views

•

06:39 min

•

October 03, 2018

DOI:

10.3791/58140-v

DOI:
10.3791/58140-v

•

06:39 min
October 03, 2018

•

1 Views
, , ,
1Genetics Branch,Center for Cancer Research, National Cancer Institute, National Institutes of Health, 2LGI Flow Cytometry Core Facility,Center for Cancer Research, National Cancer Institute, National Institutes of Health

Explore More Videos

Hematopoietic Stem Cell TransplantationMyelodysplastic SyndromeCancer Stem CellsFunctional AnalysisDisease Initiating CellsAdoptive TransferTotal Body IrradiationBone Marrow Nucleated CellsFlow SortingBiotinylated Anti-lineage AntibodyAPC Conjugated Anti-Sca1 Antibody

Read Article

Cite this Article

Chung, Y. J., Khawaja, G., Wolcott, K. M., Aplan, P. D. Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome. J. Vis. Exp. (140), e58140, doi:10.3791/58140 (2018).

Download .ris file

Copy

Share Video

.

Copy